Bolan Woodward, MD
Obstetrics & Gynecology · Valdosta, GANPI 1699851337
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $634 and has fallen 90.1% since, to $63 in 2025.
Across 164 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$709
- Pfizer$319
- AbbVie$278
- Amgen$236
- Hologic Sales And Service, LLC$166
- Bayer$161
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,89096%
- Education$1094%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 38 | $709 |
| Pfizer | 19 | $319 |
| AbbVie | 15 | $278 |
| Amgen | 16 | $236 |
| Hologic Sales And Service, LLC | 8 | $166 |
| Bayer | 10 | $161 |
| Evofem Biosciences, Inc. | 5 | $93 |
| Merck | 5 | $84 |
| Therapeuticsmd, Inc. | 5 | $80 |
| Biohaven Pharmaceuticals, Inc. | 4 | $69 |
| Baxter Healthcare | 2 | $68 |
| Daiichi Sankyo Inc. | 3 | $63 |
| Organon | 4 | $63 |
| Myriad Women's Health, Inc. | 1 | $59 |
| Novo Nordisk | 1 | $47 |
| Cepheid | 1 | $45 |
| Shield Therapeutics Inc | 2 | $45 |
| Avion Pharmaceuticals | 3 | $44 |
| Pacira Pharmaceuticals Incorporated | 2 | $42 |
| Optumhealth Care Solutions, LLC | 2 | $41 |
| Lupin Inc. | 2 | $36 |
| Coloplast | 2 | $31 |
| Aspira Women's Health Inc | 2 | $29 |
| Axonics, Inc. | 1 | $22 |
| Urovant Sciences Inc | 1 | $19 |
| Virtus Pharmaceuticals LLC | 1 | $19 |
| Duchesnay USA Incorporated | 1 | $18 |
| Channel Medsystems, Inc. | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Olympus America Inc. | 1 | $14 |
| Coopersurgical, Inc. | 1 | $13 |
| Dysis Medical, Inc. | 1 | $11 |
| Meditrina | 1 | $10 |
How this compares
$2,998 in reported general payments places this provider in the 80th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Risedronate Sodium | 16 | $1,260 |
| Estradiol | 11 | $678 |
| Betamethasone Valerate | 13 | $363 |
| Alendronate Sodium | 25 | $197 |
| Escitalopram Oxalate | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Valdosta
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
- Teresa ByrdMarietta$41K
- Christopher BassilSuwanee$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.